MARGARET MANDELSON

Summary

Affiliation: Group Health Cooperative
Country: USA

Publications

  1. ncbi Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers
    M T Mandelson
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    J Natl Cancer Inst 92:1081-7. 2000
  2. ncbi Colorectal cancer screening participation by older women
    M T Mandelson
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Am J Prev Med 19:149-54. 2000
  3. ncbi Hormone replacement therapy in relation to survival in women diagnosed with colon cancer
    Margaret T Mandelson
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Cancer Causes Control 14:979-84. 2003
  4. ncbi Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients
    Stephen J Rulyak
    University of Washington, Division of Gastroenterology, Harborview Medical Center, Seattle, Washington 98104, USA
    Clin Gastroenterol Hepatol 5:470-6; quiz 407. 2007
  5. ncbi Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization
    Matthew Kerrigan
    Department of Pharmacy, University of Washington, Seattle, and the Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, Washington 98109, USA
    Med Care 43:1043-8. 2005
  6. ncbi Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk
    Victoria M Chia
    Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 16:2697-703. 2007
  7. ncbi Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research
    Sally W Vernon
    Cancer Epidemiol Biomarkers Prev 13:898-905. 2004
  8. ncbi Health plan policies and programs for colorectal cancer screening: a national profile
    Carrie N Klabunde
    Division of Cancer Control and Population Sciences, National Cancer Institute NCI, Executive Plaza North Room 4005, 6130 Executive Boulevard, Bethesda, MD 20892 7344, USA
    Am J Manag Care 10:273-9. 2004
  9. ncbi Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer
    Stephen J Rulyak
    University of Washington, Department of Medicine, Seattle, Washington, USA
    Gastrointest Endosc 59:239-47. 2004
  10. ncbi Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, USA
    Gastroenterology 125:1645-50. 2003

Research Grants

  1. Medical History, Medications, and Pancreatic Cancer Risk
    MARGARET MANDELSON; Fiscal Year: 2004
  2. Multi-Center Study of Pancreatic Cancer Etiology
    MARGARET MANDELSON; Fiscal Year: 2009

Collaborators

Detail Information

Publications12

  1. ncbi Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers
    M T Mandelson
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    J Natl Cancer Inst 92:1081-7. 2000
    ..Cancers diagnosed after a negative mammogram are known as interval cancers. This study investigated whether mammographic breast density is related to the risk of interval cancer...
  2. ncbi Colorectal cancer screening participation by older women
    M T Mandelson
    Center for Health Studies, Group Health Cooperative, Seattle, Washington, USA
    Am J Prev Med 19:149-54. 2000
    ..Systematic efforts to increase awareness of colorectal cancer (CRC) and to promote screening participation are needed to meet national objectives for CRC control...
  3. ncbi Hormone replacement therapy in relation to survival in women diagnosed with colon cancer
    Margaret T Mandelson
    Center for Health Studies, Group Health Cooperative, Seattle, WA 98101, USA
    Cancer Causes Control 14:979-84. 2003
    ....
  4. ncbi Outcome of follow-up colon examination among a population-based cohort of colorectal cancer patients
    Stephen J Rulyak
    University of Washington, Division of Gastroenterology, Harborview Medical Center, Seattle, Washington 98104, USA
    Clin Gastroenterol Hepatol 5:470-6; quiz 407. 2007
    ..We sought to estimate survival among colorectal cancer patients according to receipt of a follow-up colon examination and to describe the findings of such exams...
  5. ncbi Costs and survival of patients with colorectal cancer in a health maintenance organization and a preferred provider organization
    Matthew Kerrigan
    Department of Pharmacy, University of Washington, Seattle, and the Fred Hutchinson Cancer Research Center, Public Health Sciences Division, Seattle, Washington 98109, USA
    Med Care 43:1043-8. 2005
    ..CONCLUSIONS: There were differences in the initial treatment of the patients in each health plan, but costs and survival were not significantly different between the 2 plans...
  6. ncbi Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk
    Victoria M Chia
    Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109 1024, USA
    Cancer Epidemiol Biomarkers Prev 16:2697-703. 2007
    ..There were no associations of leptin receptor genotypes or haplotypes and adenoma risk. The results of this study suggest that, in men, leptin may be associated with risk of colorectal adenomas...
  7. ncbi Measures for ascertaining use of colorectal cancer screening in behavioral, health services, and epidemiologic research
    Sally W Vernon
    Cancer Epidemiol Biomarkers Prev 13:898-905. 2004
  8. ncbi Health plan policies and programs for colorectal cancer screening: a national profile
    Carrie N Klabunde
    Division of Cancer Control and Population Sciences, National Cancer Institute NCI, Executive Plaza North Room 4005, 6130 Executive Boulevard, Bethesda, MD 20892 7344, USA
    Am J Manag Care 10:273-9. 2004
    ..A consensus has emerged that average-risk adults 50 years of age or older should be screened for colorectal cancer (CRC)...
  9. ncbi Clinical and sociodemographic factors associated with colon surveillance among patients with a history of colorectal cancer
    Stephen J Rulyak
    University of Washington, Department of Medicine, Seattle, Washington, USA
    Gastrointest Endosc 59:239-47. 2004
    ..CONCLUSIONS: There is substantial variability in the use of colon examination for surveillance in patients with a history of colorectal cancer, and clinical and sociodemographic factors appear to influence the likelihood of surveillance...
  10. ncbi Cancer-attributable costs of diagnosis and care for persons with screen-detected versus symptom-detected colorectal cancer
    Scott D Ramsey
    Public Health Sciences Division, Fred Hutchinson Cancer Research Center, and Department of Medicine, University of Washington, Seattle, USA
    Gastroenterology 125:1645-50. 2003
    ..01). CONCLUSIONS: Colorectal cancer screening can substantially reduce prediagnosis evaluation costs. These savings are of interest to health plans and should be factored into cost-effectiveness evaluations of screening programs...
  11. ncbi Predictors of sensitivity of clinical breast examination (CBE)
    Nina Oestreicher
    Fred Hutchinson Cancer Research Center, University of Washington, Seattle, USA
    Breast Cancer Res Treat 76:73-81. 2002
    ..s. age 50-59 years). These findings suggest certain groups of women, for example, obese women and younger women, receive less benefit from CBE...
  12. ncbi Ulcerative colitis is a disease of accelerated colon aging: evidence from telomere attrition and DNA damage
    Rosa Ana Risques
    Department of Pathology, University of Washington, Seattle, Washington, USA
    Gastroenterology 135:410-8. 2008
    ..We explored this hypothesis in ulcerative colitis (UC), a chronic inflammatory disease that predisposes to colorectal cancer and in which shorter telomeres have been associated with chromosomal instability and tumor progression...

Research Grants3

  1. Medical History, Medications, and Pancreatic Cancer Risk
    MARGARET MANDELSON; Fiscal Year: 2004
    ..abstract_text> ..
  2. Multi-Center Study of Pancreatic Cancer Etiology
    MARGARET MANDELSON; Fiscal Year: 2009
    ..abstract_text> ..